News Conference News ESC 2025 BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension Todd Neale August 31, 2025
News Conference News ESC 2024 More Data Diminish Support for Cath Lab Fasting Rules: SCOFF L.A. McKeown September 10, 2024
News Conference News ESC 2024 Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery Todd Neale August 30, 2024
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Conference News ESC 2021 STEP Trial Supports Lower BP Goal in Older Patients With Hypertension Todd Neale August 30, 2021
News Conference News ESC 2020 Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC Shelley Wood August 31, 2020
News Conference News ESC 2018 Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy Michael O'Riordan August 27, 2018
News Conference News ESC 2016 Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD Todd Neale September 09, 2016
News Conference News ESC 2013 AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction Caitlin E. Cox September 04, 2013